patients weighing less than 50 kilograms, 150 micrograms (one nasal spray) per dose
Sponsors
Shiraz University of Medical Sciences
Conditions
Condition 1: Bleeding. Condition 2: Kidney biopsy.
Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedureCondition 1: Bleeding. Condition 2: Kidney biopsy. Condition 3: Acute kidney failure.
Postprocedural hemorrhage and hematoma of skin and subcutaneous tissue following other procedure
Acute kidney failure, unspecified
Phase 3
Evaluation of the effect of intranasal desmopressin spray on the complications of kidney biopsy in renal failure
Active, not recruitingIRCT20201019049075N1
Start: 2019-12-22Target: 60Updated: 2021-08-30
Evaluation of the effect of intranasal desmopressin spray on complications of kidney biopsy
Active, not recruitingIRCT20201019049075N2
Start: 2019-04-04Target: 60Updated: 2021-11-01